UniProt ID | ATG4B_HUMAN | |
---|---|---|
UniProt AC | Q9Y4P1 | |
Protein Name | Cysteine protease ATG4B | |
Gene Name | ATG4B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 393 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Cysteine protease required for the cytoplasm to vacuole transport (Cvt) and autophagy. Cleaves the C-terminal amino acid of ATG8 family proteins MAP1LC3, GABARAPL1, GABARAPL2 and GABARAP, to reveal a C-terminal glycine. Exposure of the glycine at the C-terminus is essential for ATG8 proteins conjugation to phosphatidylethanolamine (PE) and insertion to membranes, which is necessary for autophagy. Has also an activity of delipidating enzyme for the PE-conjugated forms.. | |
Protein Sequence | MDAATLTYDTLRFAEFEDFPETSEPVWILGRKYSIFTEKDEILSDVASRLWFTYRKNFPAIGGTGPTSDTGWGCMLRCGQMIFAQALVCRHLGRDWRWTQRKRQPDSYFSVLNAFIDRKDSYYSIHQIAQMGVGEGKSIGQWYGPNTVAQVLKKLAVFDTWSSLAVHIAMDNTVVMEEIRRLCRTSVPCAGATAFPADSDRHCNGFPAGAEVTNRPSPWRPLVLLIPLRLGLTDINEAYVETLKHCFMMPQSLGVIGGKPNSAHYFIGYVGEELIYLDPHTTQPAVEPTDGCFIPDESFHCQHPPCRMSIAELDPSIAVGFFCKTEDDFNDWCQQVKKLSLLGGALPMFELVELQPSHLACPDVLNLSLDSSDVERLERFFDSEDEDFEILSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDAATLTY -------CCCCCCCC | 7.74 | 22223895 | |
5 | Phosphorylation | ---MDAATLTYDTLR ---CCCCCCCCCHHH | 22.73 | 28111955 | |
7 | Phosphorylation | -MDAATLTYDTLRFA -CCCCCCCCCHHHHH | 18.26 | 28442448 | |
8 | Phosphorylation | MDAATLTYDTLRFAE CCCCCCCCCHHHHHC | 15.28 | 25106551 | |
10 | Phosphorylation | AATLTYDTLRFAEFE CCCCCCCHHHHHCCC | 14.93 | 28442448 | |
33 | Phosphorylation | VWILGRKYSIFTEKD EEECCCCEEECCCHH | 12.97 | 26434776 | |
34 | Phosphorylation | WILGRKYSIFTEKDE EECCCCEEECCCHHH | 17.79 | 25849741 | |
37 | Phosphorylation | GRKYSIFTEKDEILS CCCEEECCCHHHHHH | 40.22 | 26434776 | |
39 | Ubiquitination | KYSIFTEKDEILSDV CEEECCCHHHHHHHH | 58.57 | - | |
44 | Phosphorylation | TEKDEILSDVASRLW CCHHHHHHHHHHHHH | 35.38 | 26434776 | |
69 (in isoform 2) | Phosphorylation | - | 52.28 | - | |
79 (in isoform 3) | Ubiquitination | - | 17.41 | 21906983 | |
96 (in isoform 2) | Phosphorylation | - | 9.06 | 28064214 | |
102 | Ubiquitination | DWRWTQRKRQPDSYF CCCCCCCCCCCCCCH | 45.63 | - | |
119 | Ubiquitination | LNAFIDRKDSYYSIH HHHHHCCCCCCEEHH | 47.48 | - | |
122 | Phosphorylation | FIDRKDSYYSIHQIA HHCCCCCCEEHHHHH | 16.03 | - | |
123 | Phosphorylation | IDRKDSYYSIHQIAQ HCCCCCCEEHHHHHH | 12.71 | - | |
153 (in isoform 1) | Ubiquitination | - | 47.05 | 21906983 | |
153 (in isoform 6) | Ubiquitination | - | 47.05 | 21906983 | |
153 | Ubiquitination | NTVAQVLKKLAVFDT HHHHHHHHHHHCHHC | 47.05 | 2190698 | |
207 (in isoform 2) | Ubiquitination | - | 31.05 | - | |
241 (in isoform 2) | Ubiquitination | - | 35.43 | 21906983 | |
242 (in isoform 2) | Ubiquitination | - | 30.94 | - | |
270 (in isoform 4) | Ubiquitination | - | 7.02 | 21906983 | |
316 | Phosphorylation | SIAELDPSIAVGFFC EHHHCCCCEEEEEEE | 23.89 | 18187866 | |
321 (in isoform 4) | Phosphorylation | - | 5.37 | 29507054 | |
337 | Ubiquitination | NDWCQQVKKLSLLGG HHHHHHHHHHHHHCC | 43.59 | - | |
337 | Acetylation | NDWCQQVKKLSLLGG HHHHHHHHHHHHHCC | 43.59 | 25953088 | |
368 | Phosphorylation | CPDVLNLSLDSSDVE CCCCCCCCCCHHHHH | 29.11 | 28464451 | |
383 | Phosphorylation | RLERFFDSEDEDFEI HHHHHHCCCCCCCEE | 41.62 | 19664994 | |
392 | Phosphorylation | DEDFEILSL------ CCCCEEECC------ | 37.38 | 25159151 | |
425 (in isoform 2) | Ubiquitination | - | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ATG4B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATG4B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GBRL1_HUMAN | GABARAPL1 | physical | 20562859 | |
GBRAP_HUMAN | GABARAP | physical | 20562859 | |
GBRL2_HUMAN | GABARAPL2 | physical | 20562859 | |
ANXA1_HUMAN | ANXA1 | physical | 20562859 | |
GBRL1_HUMAN | GABARAPL1 | physical | 16704426 | |
MLP3B_HUMAN | MAP1LC3B | physical | 15355958 | |
MLP3A_HUMAN | MAP1LC3A | physical | 19322194 | |
MLP3A_HUMAN | MAP1LC3A | physical | 19549685 | |
GBRL2_HUMAN | GABARAPL2 | physical | 19549685 | |
GBRL1_HUMAN | GABARAPL1 | physical | 19549685 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-316, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383 AND SER-392, ANDMASS SPECTROMETRY. |